Next-generation medium delivers up to 61% higher titers 1, faster workflows, and greater flexibility for insulin-dependent CHO cell lines WALTHAM, Mass.--(BUSINESS WIRE)--Thermo Fisher Scientific Inc.
Next-generation medium delivers up to 61% higher titers 1, faster workflows, and greater flexibility for insulin-dependent CHO cell lines Designed for Biopharma Manufacturers, Biotechnology Companies, ...
Thermo Fisher Scientific Inc. (NYSE: TMO) is the world leader in serving science, with annual revenue of over $40 billion. Our Mission is to enable our customers to make the world healthier, cleaner ...
Discover how precision fermentation and mass spectrometry are transforming collagen production for sustainable biofoods.
If you enjoyed this article, I’d like to ask for your support. Scientific American has served as an advocate for science and industry for 180 years, and right now may be the most critical moment in ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback